Fund Holdings — Atlas Venture Life Science Advisors, LLC

Total Portfolio Value:
$839.75M
Total Bought:
$53.65M
Total Sold:
$18.61M
Net Transaction:
+$35.04M
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Kymera Therapeutics, Inc.(KYMR)5,858,2625,858,2620$81.43M$149.15M17.76%+$67.72M
Disc Medicine, Inc.(IRON)2,745,3352,555,172-190,163$128.98M$147.59M17.58%+$18.61M
Dyne Therapeutics, Inc.(DYN)9,885,4499,885,4490$88.57M$131.48M15.66%+$42.90M
Third Harmonic Bio, Inc.10,907,85910,907,8590$69.70M$119.66M14.25%+$49.96M
Day One Biopharmaceuticals, Inc.
COM
7,608,3947,608,3940$93.35M$111.08M13.23%+$17.73M
Korro Bio, Inc.(KRRO)01,119,292+1,119,292$0$53.65M6.39%+$53.65M
Aerovate Therapeutics, Inc.2,039,2492,039,2490$27.67M$46.15M5.50%+$18.48M
Vigil Neuroscience, Inc.5,836,8745,836,8740$31.46M$19.73M2.35%-$11.73M
Replimune Group, Inc.(REPL)2,098,3002,098,3000$35.90M$17.69M2.11%-$18.21M
Generation Bio, Co.8,279,4848,279,4840$31.38M$13.66M1.63%-$17.72M
Ikena Oncology, Inc.5,018,1785,018,1780$21.73M$9.89M1.18%-$11.84M
Akero Therapeutics, Inc.359,251359,2510$18.17M$8.39M1.00%-$9.78M
AvroBio, Inc.4,541,3814,541,3810$6.99M$6.18M0.74%-$817.4K
Dianthus Therapeutics, Inc.(DNTH)236,979236,9790$3.24M$2.46M0.29%-$774.9K
Xilio Therapeutics, Inc.(XLO)2,759,3442,759,3440$5.82M$1.52M0.18%-$4.30M
Spero Therapeutics, Inc.(SPRO)1,013,4381,013,4380$1.23M$1.49M0.18%+$263.5K
Page 1 of 1
Atlas Venture Life Science Advisors, LLC — 13F Holdings — Q4 2023 | TickerTrail